EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients

J Allergy Clin Immunol. 2017 Dec;140(6):1703-1705. doi: 10.1016/j.jaci.2017.06.046. Epub 2017 Aug 16.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Chemokine CCL17 / blood*
  • Dermatitis, Atopic / blood*
  • Humans
  • Interleukin-22
  • Interleukins / blood*
  • Receptors, Interleukin-2 / blood*
  • Severity of Illness Index*

Substances

  • Biomarkers
  • CCL17 protein, human
  • Chemokine CCL17
  • Interleukins
  • Receptors, Interleukin-2